Skip to main content
Top

Drugs

Issue 14/2023

Content (9 Articles)

Pyoderma Gangrenosum: Treatment Options

Joachim Dissemond, Angelo V. Marzano, Philip J. Hampton, Alex G. Ortega-Loayza

Pharmacological Management of Orofacial Pain

Marcela Romero-Reyes, Sherwin Arman, Antonia Teruel, Satish Kumar, James Hawkins, Simon Akerman

Clinical Outcomes with GLP-1 Receptor Agonists in Patients with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Huilei Zhao, Yang Liu, Menglu Liu, Yi Xu, Qin Ling, Weichun Lin, Jing Zhang, Zhiwei Yan, Jianyong Ma, Weiguang Li, Yujie Zhao, Peng Yu, Xiao Liu, Jingfeng Wang

Ritlecitinib: First Approval

Hannah A. Blair

Epcoritamab: First Approval

James E. Frampton

Rozanolixizumab: First Approval

Sheridan M. Hoy

Correction to: Remdesivir: A Review in COVID-19

Hannah A. Blair

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images